CompoAtlas

Reversitol

Finding published by the FDA

Finding published by the FDA

Finding date: 16 September 2010.

Contains 6-Etioallochol-1,4-Diene-3,17-Dione, also known as ATD

FDA finding date
16 September 2010
Company
Tribravus Enterprises, LLC
Subject published by the FDA
Contains 6-Etioallochol-1,4-Diene-3,17-Dione, also known as ATD
Published action
Recall
Programme
Drugs

This official finding is dated and does not necessarily describe the product currently sold under this name. It does not constitute an analysis of its complete composition.

The subject and action are reproduced as published by the FDA, without generalisation to all batches or other products from the company.

Substances named in the FDA finding

Published namePublished text and quantityRecognised ingredientRole or context
6-Etioallochol-1,4-Diene-3,17-Dione, also known as ATDContains 6-Etioallochol-1,4-Diene-3,17-Dione, also known as ATDNot recognisedSubstance named by the FDA

Substances named in the FDA finding do not constitute a complete composition. No quantity or dose is inferred.

Sites cited by the FDA

n/a

Official source

View the FDA finding

Food and Drug Administration, Health Fraud Product Database. Dated official findings.

Domaine public (politique du site FDA)

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Reversitol”, https://compoatlas.com/en/supplements/us-fraud/e8f19f88764534e05f5ec3e17bb431beb5f3e4b1c2481e59b9e9f02c8bd28824-reversitol, updated 28 October 2026.

Enter to analyse, Shift+Enter for a new line